Michael Robinson is a Psychiatry physician. ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
998 Library Ct
Oregon City, OR 970454041
Telephone
503-655-8401Registry record last updated 9 Apr 2018.
Clinical trials
- Mechanisms and Modulation of Pain Modulatory Capacity
Sponsor: University of Florida
- Health Behaviors and Time-of-Day: Older Adult Cognitive Function
Sponsor: University of Florida
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
96.9%Atypical Antipsychotic36.1%Aripiprazole23%Clozapine18%Quetiapine Fumarate16%Olanzapine14%Risperidone11%Abilify Maintena4%Lurasidone Hcl2%Rexulti2%Vraylar2%Invega Sustenna2%Quetiapine Fumarate Er2%Paliperidone Er1%Asenapine Maleate1%Invega Trinza1%Part D<11 patientsSSRI25.4%Trazodone Hcl36%Fluoxetine Hcl18%Sertraline Hcl15%Escitalopram Oxalate9%Fluvoxamine Maleate8%Paroxetine Hcl6%Citalopram Hbr6%Paroxetine Er2%Part D<11 patients+ 15 more classes in this area
Cardiovascular
2.7%Central alpha-2 Adrenergic Agonist1.7%Clonidine Hcl77%Guanfacine Hcl24%Part D<11 patientsalpha-Adrenergic Blocker0.9%Prazosin Hcl100%Part D<11 patientsMetabolism & gastrointestinal
0.4%Proton pump inhibitor0.4%Pantoprazole Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Philip Scheltens
Inserm
Rafael Tabarés‐Seisdedos
Universitat de València
Nick C. Fox
UK Dementia Research Institute
Perminder S. Sachdev
Department of Health and Aged Care
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”